Ischaemic change after intravitreal bevacizumab (Avastin®) injection for macular oedema secondary to non-ischaemic central retinal vein occlusion

被引:44
作者
Kim, Kwan Soo [1 ]
Chang, Hae Ran [1 ]
Song, Sujeong [1 ]
机构
[1] Sungkyunkwan Univ, Coll Med, Dept Ophthalmol, Kangbuk Samsung Hosp, Seoul 110746, South Korea
关键词
D O I
10.1111/j.1755-3768.2008.01175.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页数:3
相关论文
共 4 条
[1]  
Clarkson JC, 1997, ARCH OPHTHALMOL-CHIC, V115, P486
[2]  
ITURRALDE D, 2006, ACTA OPHTHALMOL SCAN, V84, P555
[3]   Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion [J].
Pai, Sivakami A. ;
Shetty, Rohit ;
Vijayan, Priya B. ;
Venkatasubramaniam, G. ;
Yadav, Naresh K. ;
Shetty, Bhujang K. ;
Babu, Rajesh B. ;
Narayana, Kannan M. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (04) :601-606
[4]   Intravitreal bevacizumab treatment of macular oedema due to central retinal vein occlusion [J].
Spandau, Ulrich H. M. ;
Ihloff, Anna K. ;
Jonas, Jost B. .
ACTA OPHTHALMOLOGICA SCANDINAVICA, 2006, 84 (04) :555-556